Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol

NCT01695668 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT01695668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01695668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2011
Completion date
February 28, 2015
Enrollment
75 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dry eyes